Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Diltiazem and Tranexamic Acid in FESS
NCT03580590Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Sep 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in sinusitis and acute sinusitis comparing Diltiazem, Diltiazem + TXA and Placebo (3 arms). Primary endpoint: Estimated Blood Loss. Status: unknown.
02
Drugs
diltiazemtranexamic acid
03
Conditions
sinusitisacute sinusitis
Beyond the preview
Go deeper on NCT03580590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03580590.